Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells
about
Involvement of FKBP6 in hepatitis C virus replicationSelective targeting of the stress chaperome as a therapeutic strategyA locus encompassing the Epstein-Barr virus bglf4 kinase regulates expression of genes encoding viral structural proteinsRole for heat shock protein 90α in the proliferation and migration of HaCaT cells and in the deep second-degree burn wound healing in mice.Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.The co-chaperone Cdc37 regulates the rabies virus phosphoprotein stability by targeting to Hsp90AA1 machinery.HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-κB activation and HTLV-1 replicationBromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.Ganetespib, an HSP90 inhibitor, kills Epstein-Barr virus (EBV)-infected B and T cells and reduces the percentage of EBV-infected cells in the blood.Interindividual Spread of Herpesviruses.HSP90: a promising broad-spectrum antiviral drug target.Combined PI3K/Akt and Hsp90 targeting synergistically suppresses essential functions of alloreactive T cells and increases Tregs.Human Cytomegalovirus Nuclear Capsids Associate with the Core Nuclear Egress Complex and the Viral Protein Kinase pUL97.
P2860
Q28115857-71F88E5D-BA8B-4A25-919A-6E6142E546D7Q28248791-8EF35535-4B54-43AB-9EEF-AA567BDE166FQ34105467-771DF5FB-AEE2-4460-98DD-F306A80E0D0DQ35222831-14C63A04-4464-4DB5-8C51-EB3782DC615EQ35925834-97AC0217-960C-4423-AE09-994F20B51130Q36959539-95942FD0-6445-4AB9-94D3-8FFEA489A51EQ37336808-CBB5A2FB-6989-4CC7-8C60-1760A11B2A93Q38701064-F4388BCC-1412-4068-BADB-8ADE259170F5Q38743134-C5C44E3F-E3A7-4037-A47F-13FA1B89EA0EQ39320366-776465A3-9D01-47ED-92E4-015962844691Q40093256-0F2C79BC-7CA6-44F6-8977-D381DB2085F2Q41057184-AF8543B7-4021-4968-AD93-58189643B3EAQ47552402-52469F64-BEF2-4ADB-B513-1BB2DD6D622E
P2860
Hsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hsp90 inhibitor 17-DMAG decrea ...... tein-Barr virus-infected cells
@en
Hsp90 inhibitor 17-DMAG decrea ...... ein-Barr virus-infected cells.
@nl
type
label
Hsp90 inhibitor 17-DMAG decrea ...... tein-Barr virus-infected cells
@en
Hsp90 inhibitor 17-DMAG decrea ...... ein-Barr virus-infected cells.
@nl
prefLabel
Hsp90 inhibitor 17-DMAG decrea ...... tein-Barr virus-infected cells
@en
Hsp90 inhibitor 17-DMAG decrea ...... ein-Barr virus-infected cells.
@nl
P2093
P2860
P356
P1433
P1476
Hsp90 inhibitor 17-DMAG decrea ...... tein-Barr virus-infected cells
@en
P2093
Elizabeth A Barlow
Joyce D Fingeroth
Robert F Kalejta
Satoko Iwahori
Shannon C Kenney
Stacy R Hagemeier
Vera L Tarakanova
Xiaoping Sun
P2860
P304
10126-10138
P356
10.1128/JVI.01671-13
P407
P577
2013-07-10T00:00:00Z